f it feels like you’ve been hearing from the head of the Food and Drug Administration a lot lately, you’re not imagining it.

It’s a rare day here at STAT when we don’t receive in our inboxes a “Statement from FDA Commissioner Scott Gottlieb, M.D.” — or at least find him prominently quoted in another new FDA press release. Then there are all his blog posts. His speeches. His congressional testimony. And, of course, his tweets.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Now that you’ve gotten mired in Gottlieb word count, please address the content. I’d say, based on STAT News reportage and those of many other outlets, the man has ‘something worthwhile to say.’ On the other hand, maybe I’m only seeing the ‘cream of the crop’?

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.